Business & regional news

La technologie TYRX de nouvelle génération est maintenant offerte au Canada aux patients porteurs de dispositifs cardiaques implantables ou de dispositifs de neuromodulation.

The next-generation TYRX technology is now available in Canada for patients who receive implantable cardiac or neuromodulation devices

Featured clinical science presentation highlights global randomized trial investigating TAVR intervention alongside guideline-directed medical therapy

• Up to 100 scholarships will be awarded globally to students pursuing degrees or credentials in health tech fields.
• Applications open October 26, 2026, and close on January 15, 2027.

Recognition highlights Medtronic's commitment to creating a workplace where employees can grow, innovate and deliver meaningful impact through the company's Mission.

Navigated blades will connect powered instrumentation and navigation to offer surgeons greater visibility and flexibility in sinus procedures Oct. 7, 2026 – Medtronic, a global leader in...

At 47^th AUGS Annual Scientific Meeting, Medtronic advances Altaviva^TM clinical program with 24-month exploratory findings from TITAN 2 showing sustained reductions in nightly nocturia episodes and announces partnership to advance patient awareness of pelvic floor disorders

News comes on heels of recent expanded U.S. payer coverage, reaching 96% of commercially and Medicare insured lives, expanding greater access to care Medtronic, a global leader in healthcare...

Investigational device to be studied in pre-market, randomized pivotal trial

Company recognized for improving healthcare outcomes through technology

A next-generation blade designed to improve efficiency in paranasal sinus surgery

More than 23 procedures performed across seven sites in Germany, the United Kingdom, Italy, and Spain

Following recent U.S. Food and Drug Administration (FDA) labeling approval, European label milestone reinforces Medtronic leadership in advancing aortic care based on clinical evidence supporting the treatment of ruptured abdominal aortic aneurysms (rAAA).

GALWAY, Ireland, September 2, 2026 – Medtronic (NYSE: MDT), a global leader in healthcare technology announced that the Centers for Medicare and Medicaid Services (CMS) has granted a New...

Lower viscosity formulation designed to enable more distal penetration with 1-minute shake time

New 11-bed facility at Apollo Jubilee Hills to feature integrated Acute Care & Monitoring technologies and serve as a real-world clinical innovation hub for Medtronic R&D.

New, enhanced visualization†, seamless streaming, retrospective recording, and other advanced features to support the clinical need to intubate with first-pass success^‡,1,2

Following recent U.S. FDA clearance, Medtronic expands access to its next-generation ENT navigation platform across Europe

The FDA cleared multi-parameter wearable designed for continuous monitoring of vital signs enhances the Acute Care & Monitoring portfolio of patient monitoring solutions.